SCHEMBL8084436

SCHEMBL8084436

CCCC(Cc1ccccc1)N(C)CCC(C)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.43
OPRK1 P41145 3/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
ADRA1A P35348 2/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41
AOC3 Q16853 1/20 0.39
RIPK1 Q13546 1/20 0.39
MAOB P27338 4/20 0.38
OPRM1 P35372 2/20 0.38
MAOA P21397 2/20 0.38
ADRA2A P08913 1/20 0.38
SNCA P37840 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11401889 0.80 CARM1 (0.46) SIGMAR1OPRK1ADRA2BADRA2CADRA1A
SCHEMBL8091031 0.79 SIGMAR1 (0.62) SIGMAR1ADRA1ASLC6A2SLC6A4SLC6A3
SCHEMBL11117786 0.76 OPRK1 (0.48) SIGMAR1OPRK1ADRA2BADRA2CADRA1A
Hydrochloric Acid SCHEMBL5092786 0.74 OPRK1 (0.47) SIGMAR1OPRK1ADRA2BADRA2CADRA1A
Bromide SCHEMBL5092308 0.74 OPRK1 (0.47) SIGMAR1OPRK1ADRA2BADRA2CADRA1A
Iodide SCHEMBL5092821 0.74 OPRK1 (0.47) SIGMAR1OPRK1ADRA2BADRA2CADRA1A
SCHEMBL190949 0.73 RIPK1 (0.59) AOC3RIPK1
SCHEMBL3427848 0.71 HTR2A (0.69) OPRK1ADRA2BADRA1ASLC6A2HTR2A
SCHEMBL22515947 0.71 HTR2A (0.69) OPRK1ADRA2BADRA1ASLC6A2HTR2A
SCHEMBL19121804 0.71 HTR2A (0.69) OPRK1ADRA2BADRA1ASLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0612319-A1 BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-08-31 EP disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1994004525-A1 BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-03-03 WO disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed